L’autorisation d’accès précoce est octroyée à la spécialité WEGOVY (sémaglutide).
Voir aussi
Décision d'accès précoce
02/10/2023
eNrdWNty2jAQfc9XMH6XDYZw6RgyLU1aZpIpJWHa6Qsj5AVEheXowqVfX9kmLemYJhHRS14Yo7XPrqSzZ1eKLrYrVlmDkJQnXa/mV70KJITHNJl3vfHdFWp7F72zaInX+OC1ll/1a6FXIQxL2fUyqz8FnEj/+831RzDfg/B6Z5WIT5dA1KP3tKLM/4zl4gan2TuVaM1pXFmBWvC466Va5aOVSCphouhtuPgpU0wgCvYjh9blpHE4HgUZ2DNQtQRxjZN5KehMWGESLQQkqo8VzLnYlUKnIq5Nwk67Weu0rZxQOQLJtSAwxGoxFHxNY4jLp4GZBCsns018C2LNQGVOSsGDJVlJK3C8xNsR3A/Kg35vrH21VaiKaq12WG83zjths9m0ciUOlqqcPmYSQTqp1887zbARzEQQA6EZy1ESVsMQVcNWK4hJIGGFYo3CGlpqyszCoNxshgg3f+eAYkAMowXWCpD54YKqfFDixDykXCjzsLdIrDIXMcKEgESpMClDHiBkakLALPt8Y4i03lnyZJi5ZI4YQmX/Mdsd+RFw/yQTYypThnf+Uqa2S4UFNmYQRpPcTSSbwZ0wKsnMmv2Dn2jGghdGPd5rmKOIM4nsc52oI1J2NbJdiD43KbE9vqN26qu2ey5SkK8H+4sn5ZVnqKeMElt5NQKoQarxaHBcXd+qMH3AEsbCnTJ9o0nMN/L1Fe+QYY6iz7eDlYOSSdhunXda9h3PD0PmI3X3UgueQmCUkMpTBG6QzPip0mbyoxzqITveZGLkLSknmMGRphRZKq7JiIce2lnOucvnwlAK+unyzpaqXzWI3W3+txSaxt0/JLMrRy5qnEmMo4G/PM0KrfnvcaXQnEa7bndY0aJcyhZKpfJdECywLLLNN3n8lkveQcfj7sjmpK0q2syicDgKfVr0A89nim3SP9V0nXqQ2H+/P7CU+lBCwwn7UNQHZyo+uHz9wvD3FOEs7OEjIXPnJu/4c7lw1f3pafmt0UmlyOxrciWMOHyZzeiRe7SjvIyC4g6vdxYF2f1d7+w3Vb2qrw==
UPJ5xC6YehmHzYmC